This invention relates to phthalimido derivatives of the formula
##STR1##
wherein X is N or CH, and R1 to
R4 and m are as defined in the specification, as well as their pharmaceutically
acceptable salts. The invention further relates to pharmaceutical compositions
containing these compounds, a method of treating a disease by administering a therapeutically
effective amount of at least one of these compounds, and a process for their preparation
for the treatment or prevention of diseases in which MAO-B inhibitors might be beneficial.
